Page - (000353) - in Biomedical Chemistry: Current Trends and Developments

The current nanoplatforms used for the purpose of targeting drug delivery to cancer tissues can also be addressed to selectively deliver imaging agents (Chen, 2014). For example, the first evaluation of the effectiveness of a particular formulation to a patient can be performed with imaging agents, in order to verify that the delivery system will primarily target the cancerous tissues, even before any drug regimen test is initiated (Toy, 2014). However, imaging is not only used for detection, it is also important to determine the stage and the precise locations of cancer. Distribution of multistage systems have shown potential to meet the challenges of drug targeting and overcome biological barriers (Miele, 2012). Image-based nanomedicines have also a crucial importance in cancer diagnostics due to their highly sensitive detection probes (Pan,